Cheryl R. Blanchard, President, CEO, Director at Anika Therapeutics, Inc. (ANIK), bought 16,200 shares at $25.36 ($414K) on 2022-03-11, disclosed to the SEC on 2022-03-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.36 | 4,287 | $109K | 26.2% |
| 2 | $25.36 | 4,287 | $109K | 26.2% |
| 3 | $25.81 | 3,813 | $98K | 23.8% |
| 4 | $25.81 | 3,813 | $98K | 23.8% |
| Total | $25.57 avg | 16,200 | $414K | 100% |
| Filing → |
| ZMH | SELL | 2007-02-20 | $516K | — | Filing → |
| ZMH | SELL | 2007-01-31 | $1.2M | — | Filing → |